FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Siegfried Holding AG Stock AnalysisComprehensive stock analysis for Siegfried Holding AG (SGFEF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSGFEF
SGFEF
Siegfried Holding AG
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SGFEF
Home🔹Stocks🔹Siegfried Holding AG

Siegfried Holding AG

SGFEF•OTC

Siegfried Holding AG

SGFEF•OTC
Market cap
$4.58B
Sentiment

Your view on SGFEF

Mkt Cap
$4.58B
Sentiment
Your view
SGFEF
Siegfried Holding AG
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SGFEF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Siegfried Holding AG

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Marcel Imwinkelried
Headquarters
Untere Bruehlstrasse 4, Zofingen, CH
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Marcel Imwinkelried
Headquarters
Untere Bruehlstrasse 4, Zofingen, CH
Description

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News